INTRODUCTION {#s1}
============

*NDUFB11* (OMIM \*300403) variants have recently been independently proposed to cause histiocytoid cardiomyopathy (histiocytoid CM; OMIM 500000) ([@REAMCS001271C14]) and microphthalmia with linear skin defects syndrome (MLS; OMIM 309801) ([@REAMCS001271C18]). Histiocytoid CM is a rare, distinctive form of cardiomyopathy with approximately 150 cases reported worldwide, it has numerous synonyms including oncocytic cardiomyopathy ([@REAMCS001271C13]). Predominantly affecting females early in life, it is characterized by arrhythmias and associated sudden death ([@REAMCS001271C5]). Associated cardiac abnormalities include ventricular and atrial septal defects, endocardial fibroelastosis, and hypoplastic left heart syndrome ([@REAMCS001271C12]). Extracardiac features involving the nervous system and eyes are also frequently reported ([@REAMCS001271C9]). Variants in mitochondrial DNA (mtDNA) have previously been associated with histiocytoid CM ([@REAMCS001271C15]), but this has not been replicated in further studies. Histological findings in cardiac tissue often show an accumulation of excessive, aberrantly shaped mitochondria, supporting the role of mitochondrial dysfunction in the etiology ([@REAMCS001271C14]).

MLS syndrome, also known as MIDAS syndrome (microphthalmia, dermal aplasia, and sclerocornea) ([@REAMCS001271C6]), was first described in 1988 ([@REAMCS001271C1]). It is a rare X-linked disorder with male lethality in utero*,* characterized by unilateral or bilateral microphthalmia and linear skin defects. Skin defects are classically limited to the face and neck along Blaschko\'s lines, are present from birth, and heal with time, often leaving minimal scarring. Additional clinical features may include neurological and cardiac abnormalities ([@REAMCS001271C11]). Heterozygous variants in the X-encoded genes *HCCS* (OMIM \*300056) ([@REAMCS001271C19]), which encodes an important mitochondrially targeted protein, and *COX7B* (OMIM \*300885) ([@REAMCS001271C7]), which encodes a component of the mitochondrial respiratory chain (MRC), have been identified previously in MLS-affected females ([@REAMCS001271C7]). However, variants are not detected in all cases, suggesting genetic heterogeneity.

More than 20 years ago, Bird and coworkers reported an infant with the characteristic skin lesions of the then newly recognized MLS syndrome and a normal 46, XX karyotype, who died suddenly and unexpectedly at 4 mo of age. Death was attributed to oncocytic (histiocytoid) cardiomyopathy ([@REAMCS001271C2]). The authors noted that the "coexistence of two rare conditions, one of which mapped to the X Chromosome, and an excess of affected females with oncocytic cardiomyopathy, make it likely that oncocytic cardiomyopathy is also X-linked, with Xp22 being a candidate region. Overlapping manifestations in the two conditions (ocular abnormalities in cases of oncocytic cardiomyopathy and arrhythmias in MLS) offer additional support for this hypothesis" ([@REAMCS001271C2]). Here, we present evidence in support of the allelic nature of these conditions. We describe a new case of histiocytoid CM in whom we identified a de novo nonsense variant in *NDUFB11* (c.262C \> T; p.(Arg88\*)) (see [Table 1](#REAMCS001271TB1){ref-type="table"}). An identical variant has recently been reported as the molecular basis of a case of MLS syndrome. We compare the clinical features of these cases (see [Table 2](#REAMCS001271TB2){ref-type="table"}), highlighting that although each of the two entities show distinct manifestations, they share substantial phenotypic overlap and potential mechanisms are outlined.

###### 

Summary of variant of interest in *NDUFB11*

  -------------------------------- --------------------------------------------
  HGNC symbol                      *NDUFB11*
  Name                             NADH:ubiquinone oxidoreductase subunit B11
  Genomic location GRCh37 (hg19)   Chromosome X: 47002089
  HGVS cDNA                        ENST00000276062.8 c.262C \> T
  HGVS protein                     p.(Arg88\*)
  Predicted effect                 Stop gained
  Genotype                         Heterozygous
  Inheritance mode                 Sporadic
  Frequency in ExAC                0
  -------------------------------- --------------------------------------------

HGNC, HUGO Gene Nomenclature Committee; HGVS, Human Genome Variation Society; ExAC, Exome Aggregation Consortium.

###### 

Detailed comparison of the clinical features of two individuals with the same *NDUFB11* truncating variant (ENST00000276062.8: c.262C \> T; p.(Arg88\*))---one manifesting primarily as histiocytoid CM, the other with microphthalmia and linear skin defects syndrome

  Phenotypic feature                                                      Case described here (Case 1)                                                                                                                                                                                                                                                                                    Case reported by [@REAMCS001271C18]
  ----------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------
  Presenting phenotype                                                    Histiocytoid CM                                                                                                                                                                                                                                                                                                 Microphthalmia and linear skin defects syndrome
  Antenatal history                                                       Healthy, nonconsanguineous parents                                                                                                                                                                                                                                                                              Healthy, nonconsanguineous parents
                                                                          Alternating bradycardia and tachycardia noted at 27 wk; emergency Cesarean section at 38 wk for fetal tachycardia                                                                                                                                                                                               
  Sex                                                                     Female                                                                                                                                                                                                                                                                                                          Female
  Birth weight                                                            3690 g (91st centile)                                                                                                                                                                                                                                                                                           3060 g (10th--25th centile)
  Cardiac arrhythmias                                                     Neonatal episodes of supraventricular tachycardia; collapse with first documented ventricular tachycardia (VT) at 7 mo; continued VT "storms" necessitating drug treatment, dual chamber implantable cardiac defibrillator, and left thoracic sympathectomy; cardiac transplantation was carried out at 13 mo   Sudden unexpected cardiac arrest aged 6 mo; repeated treatment for ventricular arrhythmias; death within several weeks
  Cardiomyopathy                                                          Features of left ventricular noncompaction; preserved systolic function                                                                                                                                                                                                                                         Nil reported
  Cardiac histology                                                       Histiocytoid CM                                                                                                                                                                                                                                                                                                 Histiocytoid CM
  Eye abnormalities Microphthalmia Scleroderma Other eye  abnormalities   Not present Not present Intermittent squint                                                                                                                                                                                                                                                                     Nil reported Nil reported Lacrymal duct atresia
  Neuromuscular                                                           Mild-to-moderate bulbar palsy                                                                                                                                                                                                                                                                                   Axial hypotonia present from birth
  Skin abnormalities                                                      None present                                                                                                                                                                                                                                                                                                    Linear skin defects on nose, chin, and neck present at birth, disappeared in the first few months of life
  Thyroid abnormalities                                                   Focal histiocytoid change in the thyroid (and also lungs and choroid plexus of the brain)                                                                                                                                                                                                                       Oncocytic metaplasia evidence on postmortem
  Other anomalies                                                         Severe feeding difficulties gastroesophageal reflux, requiring Nissen fundoplication and percutaneous endoscopic gastrostomy                                                                                                                                                                                    Failure to thrive documented from 1 mo of age
  Evidence of somatic mosaicism                                           No evidence in DNA from lymphocytes                                                                                                                                                                                                                                                                             Yes, in DNA from lymphocytes and fibroblasts

CM, cardiomyopathy.

RESULTS {#s2}
=======

The trio sequencing approach identified two rare de novo variants, predicted to be protein altering in the proband: *NDUFB11* c.262C \> T; p.(Arg88\*) and *FAM135A* c.474C \> G; p.(Tyr158\*). Sanger sequencing confirmed the presence of both variants in the affected child and their absence in the unaffected parents (see [Fig. 1](#REAMCS001271F1){ref-type="fig"}). *NDUFB11* was a highly plausible candidate gene, located on the X Chromosome, providing a potential mechanism for the predominance of females affected (with presumed in utero male lethality), with a mitochondrial function in keeping with previous understanding of histiocytoid CM as a mitochondrial disorder. Alternative inheritance models (monoallelic or biallelic) were considered with no additional strong candidate genes identified. We interrogated four additional unrelated cases of histiocytoid CM for variants in *NDUFB11*, C*OX7B*, or *HCCS*, and no putative disease-causing variation was identified. We also reviewed publicly available WES data ([@REAMCS001271C14]) from three additional cases of histiocytoid CM without *NDUFB11* variants and found no evidence of de novo or rare variants in either *HCCS* or *COX7B*.

![(*A*) Sequence electropherogram from genomic DNA of child affected by histiocytoid cardiomyopathy (CM) from the family trio showing the *NDUFB11* variant identified by whole-exome sequencing (WES) and confirmed by Sanger sequencing. The image shows part of *NDUFB11* exon 2. Forward and reverse reads are shown. The red arrows point to the double peak in the electropherogram showing heterozygosity for the nonsense variant in *NDUFB11* c.262C \> T. The next-generation sequencing (NGS) coverage at this base was 62×, with 27 reference reads and 33 alternate reads. (*B*) Sequence electropherogram from genomic DNA of the unaffected mother from the trio showing no evidence of the *NDUFB11* sequence-level variant that had been identified in the affected child. The image shows part of *NDUFB11* exon 2. Forward and reverse reads are shown. The red arrows point to the base where the nonsense variant in *NDUFB11* c.262C \> T was detected in the affected daughter. The coverage at this base on WES was 50×, with no evidence of the variant. (*C*) Sequence electropherogram from genomic DNA of the unaffected father from the trio showing no evidence of the *NDUFB11* variant that was identified in the affected child. The image shows part of *NDUFB11* exon 2. Forward and reverse reads shown. The red arrows point to the base where the nonsense variant in *NDUFB11* c.262C \> T was detected in the affected daughter. The coverage at this base on WES was 26×, with no evidence of the variant.](ReaMCS001271_F1){#REAMCS001271F1}

DISCUSSION {#s3}
==========

At the outset of our study the molecular etiology of histiocytoid CM was unknown; we undertook WES in a trio involving an affected child (see [Fig. 2](#REAMCS001271F2){ref-type="fig"}) and both unaffected parents. This identified a de novo nonsense variant in *NDUFB11,* an X-encoded mitochondrial gene, consistent with the suspected role of mitochondrial dysfunction in histiocytoid CM ([@REAMCS001271C4]) and a de novo nonsense variant in *FAM135A*.

Simultaneous to our analyses, two independent reports showed evidence of variants in *NDUFB11* associated with histiocytoid CM ([@REAMCS001271C14]) and MLS syndrome ([@REAMCS001271C18]). The phenotypic associations of these additional variants in *NDUFB11* and ours are shown in [Table 3](#REAMCS001271TB3){ref-type="table"}. An identical variant to that reported here has recently been reported in a case of MLS in whom histiocytoid CM was found postmortem ([@REAMCS001271C18]) indicating a shared molecular basis for these conditions. Our case lacked the diagnostic features of MLS syndrome (see [Table 2](#REAMCS001271TB2){ref-type="table"}). Although *FAM135A* was not formally excluded as a candidate, there was no additional evidence to implicate a role for it in histiocytoid CM.

###### 

Catalog of variants reported in *NDUFB11,* with associated phenotypes

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                              Case 1                        Case 2                                                         Case 3^a^                                                                                      Case 4^a^                Case 5^a^                                                                Case 6            Case 7
  --------------------------- ----------------------------- -------------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------ ------------------------------------------------------------------------ ----------------- -----------------
  Reported diagnosis          Histiocytoid CM               MLS syndrome                                                   MLS syndrome                                                                                   Asymptomatic             Terminated pregnancy at 24th wk gestation                                Histiocytoid CM   Histiocytoid CM

  Sex                         Female                        Female                                                         Female                                                                                         Female                   Female                                                                   Female            Female

  Cardiac phenotype           Histiocytoid CM               Histiocytoid CM                                                Developed dilated cardiomyopathy at 2 mo of age requiring heart transplant at 6 mo of age^b^   Nil reported             Thickened myocardium\                                                    Histiocytoid CM   Histiocytoid CM
                                                                                                                                                                                                                                                   Pericardial effusion                                                                       

  Eye phenotype               Intermittent squint           Lacrimal duct atresia                                          Myopia, nystagmus, and strabismus                                                              Nil reported             Nil reported                                                             Nil reported      Nil reported

  Skin phenotype              Nil                           Linear skin defects on nose, chin, and neck present at birth   Linear and atrophic hyperpigmented streaks on face and neck                                    Nil reported             Nil reported                                                             Nil reported      Nil reported

  Protein variant^c^          p.(Arg88\*)                   p.(Arg88\*)                                                    p.(Arg134Serfs\*3)                                                                             p.(Arg134Serfs\*3)       p.(Arg134Serfs\*3)                                                       p.(Trp85\*)       p.(Tyr108\*)

  Genomic coordinate^d^       47002089                      47002089                                                       47001806                                                                                       47001806                 47001806                                                                 47002097          47002027

  Exon                        Exon 2                        Exon 2                                                         Exon 3                                                                                         Exon 3                   Exon 3                                                                   Exon 2            Exon 2

  Status                      De novo                       De novo                                                        Inherited from asymptomatic mother                                                             Unknown                  Inherited from asymptomatic mother                                       De novo           De novo

  Other phenotypic features   Bulbar palsy\                                                                                Seizures\                                                                                                               Intra-uterine growth retardation\                                                          
                              Severe feeding difficulties                                                                  Developmental delay\                                                                                                    Dysgenesis of the corpus callosum\                                                         
                                                                                                                           Agenesis of the corpus callosum\                                                                                        Small cerebellum\                                                                          
                                                                                                                           Severe muscular hypotonia\                                                                                              Connection between a lateral ventricle and the cavum septum pellucidum                     
                                                                                                                           Delayed dentition\                                                                                                                                                                                                 
                                                                                                                           Growth parameters below the 3rd centile at 15/12                                                                                                                                                                   

  Reference                   Case presented here           Subject 1^e^                                                   Subject 2^e^                                                                                   Mother of Subject 2^e^   Aborted fetus from the mother of subject 2^e^                            GHC-G^f^          GHC-T^f^
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

CM, cardiomyopathy; MLS, microphthalmia with linear skin defects.

^a^Three cases are from a single pedigree and they also have a heterozygous deletion of at least 70 kb at 2p16.3, containing part of *NRXN1,* which may have influenced the phenotype. Intragenic mutations and deletions of *NRXN1* are enriched in cohorts with neurodevelopmental and autistic spectrum disorders. Incomplete penetrance is reported.

^b^No evidence of histiocytoid CM reported, although further review of histology in light of current knowledge would be of interest.

^c^ENST00000276062.8.

^d^GRCh37(hg19).

^e^[@REAMCS001271C18].

^f^[@REAMCS001271C14].

Seventy five percent of cases of histiocytoid CM present in female infants ([@REAMCS001271C14]), often below 2 yr of age ([@REAMCS001271C5]), and the identification of *NDUFB11*, found on Xp11.23, as an underlying cause explains the large excess of affected females. There have been no molecular reports yet to confirm this as a cause of embryonic male lethality, although Shehata and coworkers comment it is "tempting to speculate that similar mutations occurring in males are embryonic lethal and cause miscarriage, since there would be no residual protein activity" ([@REAMCS001271C14]).

There is evidence for genetic heterogeneity in histiocytoid CM, as variants in *NDUFB11* and other candidate genes described here do not explain all cases. We hypothesize that *HCCS* (OMIM 30056) and *COX7B* (OMIM 300885)*,* which are X-linked genes encoding or targeting mitochondrial proteins and are implicated in MLS, are good candidate genes for histiocytoid CM. We note that [@REAMCS001271C17] have reported previously a female child with a de novo *HCCS* nonsense variant (c.589C \> T; p.(R197\*)) and extremely skewed X-inactivation (98:2) with classical features of MLS including linear skin defects on her neck, microphthalmia, anophthalmia, and sclerocornea, who died at 4 mo with ventricular tachycardia (VT) and was found to have histiocytoid CM on postmortem examination, further supporting that MLS and histiocytoid CM are allelic disorders. However, no rare variants were found in *HCCS* or *COX7B* in seven additional histiocytoid CM cases without *NDUFB11* variants (four described here, three in [@REAMCS001271C14]), though this small series does not exclude a role in "isolated" histiocytoid CM.

![Histology of histiocytoid cardiomyopathy. Longitudinal section of myocardium from an infant with histiocytoid cardiomyopathy. A few normal myocytes are present in the *lower* part of the field. The remaining cells are histiocytoid myocytes.](ReaMCS001271_F2){#REAMCS001271F2}

Comparisons (see [Table 2](#REAMCS001271TB2){ref-type="table"}) between the phenotype in the case of histiocytoid CM presented here and the case of MLS with an identical *NDUFB11* variant ([@REAMCS001271C18]) show considerable phenotypic overlap. The case of MLS also had histiocytoid CM; a feature only identified on postmortem examination. The vast majority of cases of histiocytoid CM are identified postmortem or on examination of the native explanted heart during cardiac transplantation. It is possible that additional cases of MLS also have histiocytoid CM but it remains undetected, as has previously been reported ([@REAMCS001271C2]). Previously there was no specific clinical indication to perform detailed cardiac phenotyping in MLS and so further data are lacking. [@REAMCS001271C19] reported a female, born to healthy nonconsanguineous parents after an uneventful pregnancy, found to have bilateral microphthalmia and sclerocornea but no erythematous skin lesions. She had a de novo *HCCS* nonsense variant (c.589C \> T; p.(R197\*)) that was also reported in an additional case with both MLS and histiocytoid CM ([@REAMCS001271C17]). Around 1 yr of age she was reported to have developed "idiopathic VT" ([@REAMCS001271C19]). In the absence of cardiac histology a diagnosis of histiocytoid CM cannot be confirmed, but we suggest it could underlie her VT.

Wide intra- and interfamilial variation in MLS is recognized including carrier females with variants in *HCCS* or *NDUFB11* (see [Table 2](#REAMCS001271TB2){ref-type="table"}) or terminal Xp deletions but no clinical features of MLS syndrome ([@REAMCS001271C18]). There are several potential explanations for the wide phenotypic variation including somatic mosaicism; in their case of MLS (see [Table 2](#REAMCS001271TB2){ref-type="table"}) van Rahden and coworkers noted that the mutated base thymine was present in 42 sequence reads and the wild-type base cytosine in 84, suggesting that the variant was present in mosaic state in lymphocytes. DNA isolated from fibroblasts was also suggestive of mosaicism ([@REAMCS001271C18]). In addition, [@REAMCS001271C14] note that in one of their cases with a nonsense *NDUFB11* variant (case GHCG) a second nonsense variant was detected in cytochrome *b*, but only at a frequency of 20% and only in the cardiac tissue, possibly indicating a clonal selection of a somatic variant in the diseased heart. The authors suggest this is one of the potential avenues through which the expressivity of defects in MRC complex 1 activity might be regulated ([@REAMCS001271C14]). X-inactivation may also influence phenotypic variability as the majority of MLS-affected females have severe skewing of X Chromosome inactivation suggesting that variants in causative X-linked gene(s) cause selective loss of cells in which the mutated X Chromosome is active ([@REAMCS001271C18]). Other causes of phenotypic variability could include copy-number variation or common or rare modifier variants contributing to mitochondrial function ([@REAMCS001271C14]). Furthermore, phenotypic variability may reflect differing abilities of developing tissues and organs in embryonic cells to handle a defective MRC system ([@REAMCS001271C17]).

Conclusion {#s3a}
----------

We conclude that variants in *NDUFB11* are an important cause of histiocytoid CM and report that histiocytoid CM and MLS, which are genetically heterogeneous, are allelic disorders. However, many histiocytoid CM cases remain unexplained by known genes, suggesting a heterogeneous genetic architecture with further contributing genes remaining to be discovered. Histiocytoid CM typically affects female infants \<2 yr of age and the identification of *NDUFB11*, which is found on the chromosome band Xp11.23, as an underlying cause explains the large excess of affected females. Comparison of the phenotypes of histiocytoid CM and MLS shows both considerable overlap and features specific to each entity. Differences in phenotypic expression may be due to patterns of X-inactivation, somatic mosaicism, presence of additional variants, environmental factors, or epigenetic factors. We suggest that individuals with MLS syndrome or variants or cytogenetic abnormalities involving *NDUFB11, HCCS*, or *COX7B* should be considered at risk for histiocytoid CM and screening for evidence of malignant arrhythmias and cardiomyopathy may be appropriate. Additional nuclear encoded or mtDNA genes within the MRC are good candidates for further causes of both histiocytoid CM and MLS syndrome.

METHODS {#s4}
=======

Samples {#s4a}
-------

An infant with histiocytoid CM and both unaffected parents were recruited through the NIHR Cardiovascular Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust. Four additional biologically unrelated histiocytoid cardiomyopathy probands were recruited via U.K. regional genetics services. Studies were performed according to institutional guidelines, with ethical approval.

Whole-Exome Sequencing Using a Trio Approach {#s4b}
--------------------------------------------

The trio (of affected child and both unaffected parents) underwent WES using the Agilent SureSelect system (Human All Exon v4 + UTR kit) with Illumina sequencing (HiSeq 2500, 100-bp paired-end). Reads were aligned to the human reference genome (hg19) using Burrows--Wheeler alignment (BWA) ([@REAMCS001271C8]) v0.7.5, and variants were called using the Genome Analysis Toolkit (GATK) v2.8-1 software package ([@REAMCS001271C10]) according to GATK Best Practice recommendations ([@REAMCS001271C3]; [@REAMCS001271C16]). In the affected child, mother, and father, WES generated 11.9 gigabases (Gb), 9.1 Gb and 10.4 Gb of data, respectively. The percentage callable was 99.4, 97.8, and 99.1, respectively (see [Table 4](#REAMCS001271TB4){ref-type="table"}). Variants were prioritized using the open source software platform xBrowse (<https://atgu.mgh.harvard.edu/xbrowse>). Only variants that passed standard GATK filters, with genotype quality score \>20, coverage \>20×, and allelic balance \>20, were included in the analysis. We filtered for rare (minor allele frequency \[MAF\] \<0.001 in Exome Aggregation Consortium \[ExAC\], 1000 Genomes, and xBrowse reference samples) de novo variants, predicted to be protein altering (nonsense, frameshift, essential splice site, missense, and in-frame insertion or deletion) in the proband. All inheritance models were considered.

###### 

Summary figures of coverage for WES in each sample of the family trio

  Sample              Total reads   Mapped reads   Percentage mapped   Percentage on target   Bases 10 ×   Bases 20 ×   Bases 30 ×   Percentage callable   Mean coverage   Median coverage
  ------------------- ------------- -------------- ------------------- ---------------------- ------------ ------------ ------------ --------------------- --------------- -----------------
  Affected child      11,906,7512   118,785,553    99.8                81.7                   97.8         93.4         87.6         99.4                  113             89
  Unaffected father   91,775,652    91,571,480     99.8                69.4                   91.9         80.5         70.0         97.8                  74              53
  Unaffected mother   103,827,148   103,582,562    99.8                82.8                   98.7         96.5         90.2         99.1                  101             77

The trio consists of a child affected with histiocytoid cardiomyopathy and both unaffected parents. Figures are for the coverage of the protein-coding target. Sequencing was undertaken using SureSelect Human All Exon V4 + UTR design (71 Mb) and the Illumina HiSeq 2500 platform. WES, whole-exome sequencing.

Sanger Sequencing of *NDUFB11* {#s4c}
------------------------------

The coding exons and intron--exon boundaries of *NDUFB11* were amplified by polymerase chain reaction (PCR), and directly sequenced using the BigDye Terminator Cycle Sequencing Kit and an ABI3500 Genetic Analyzer (Applied Biosystems). Sequences were analyzed using Sequencher (v5.3) software. The coding sequence of all samples was fully covered in both directions.

Sequencing Primers {#s4d}
------------------

The sequencing primers were, for *NDUFB11*, F-TCCAGCCATGACTAGAGCTG, R-TCATC TCAGCTCCCCATTCC, and for *FAM135A*, F-GTTGTACTGCAGCCTTGTAATAAAC, R-CAGCCTGAAGAACCATGACC.

ADDITIONAL INFORMATION {#s5}
======================

Data Deposition and Access {#s5a}
--------------------------

*NDUFB11* (SCV000297804.1) and *FAM135A* (SCV000297805.1) variants have been submitted to ClinVar (htpp://[www.ncbi.nlm.nih.gov/clinvar/](www.ncbi.nlm.nih.gov/clinvar/)). We do not have consent from patients to deposit complete sequencing data in a repository.
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